Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY – Get Free Report) saw a large increase in short interest in October. As of October 15th, there was short interest totaling 1,348,635 shares, an increase of 979.7% from the September 30th total of 124,913 shares. Based on an average daily volume of 837,048 shares, the short-interest ratio is presently 1.6 days. Approximately 0.1% of the company’s shares are sold short.
Coloplast A/S Trading Down 1.2%
OTCMKTS CLPBY traded down $0.09 during trading hours on Monday, hitting $7.24. 65,939 shares of the company’s stock were exchanged, compared to its average volume of 436,922. The stock has a 50-day simple moving average of $6.78 and a 200 day simple moving average of $6.47. Coloplast A/S has a 1-year low of $5.64 and a 1-year high of $9.70. The firm has a market cap of $16.32 billion, a price-to-earnings ratio of 38.11, a PEG ratio of 2.61 and a beta of 0.21. The company has a current ratio of 1.56, a quick ratio of 0.94 and a debt-to-equity ratio of 1.51.
Coloplast A/S (OTCMKTS:CLPBY – Get Free Report) last issued its quarterly earnings results on Tuesday, August 18th. The company reported $0.10 earnings per share (EPS) for the quarter, meeting the consensus estimate of $0.10. The firm had revenue of $1.14 billion for the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a return on equity of 39.27% and a net margin of 9.68%. On average, equities analysts forecast that Coloplast A/S will post 0.40 EPS for the current fiscal year.
About Coloplast A/S
Coloplast A/S is a Denmark-based medical technology company that develops, manufactures and markets products designed to help people manage intimate health conditions. Its core businesses include ostomy care, continence care, wound and skin care, and interventional urology. The company’s products are used by patients and healthcare professionals in hospitals, clinics and home-care settings.
Coloplast was founded in Denmark in 1957 after nurse Elise Sørensen helped develop an adhesive ostomy bag for her sister, who had undergone surgery.
Recommended Stories
- Five stocks we like better than Coloplast A/S
- Comfort Systems Earnings: AI Slowdown or More Growth Ahead?
- Bristol Myers Squibb’s Cancer Breakthrough Could Have Implications Beyond Its Own Stock
- 5 Beaten-Down Growth Stocks Trading Like Value Plays as Cash Chases Mega-Caps
- Anthropic’s IPO Filing Reveals a Massive Opportunity for AI Infrastructure Giants
Receive News & Ratings for Coloplast A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Coloplast A/S and related companies with MarketBeat.com's FREE daily email newsletter.
